@FiercePharma: Best-read over the weekend: Pradaxa, Xarelto makers dispute purported Eliquis safety edge. Piece | Follow @FiercePharma
@TracyStaton: The graph's the thing: Takeda admits to 'inappropriate' drug advertising in Japan. News (sub. req.) | Follow @TracyStaton
@EricPFierce: WSJ says Pfizer angling for OTC Lipitor. That will get generic drugmakers' notice. Story | Follow @EricPFierce
@CarlyHFierce: Teva's new Copaxone formula could be a hard sell with payers. Article | Follow @CarlyHFierce
> Teva ($TEVA) has launched Adasuve, an inhaled medicine to treat agitation in patients with schizophrenia or bipolar disorder, in the U.S. Report | Release
> Sanofi ($SNY) is suing Actavis ($ACT) over allegedly infringing patents on its heart drug Multaq. Report | Release
> AstraZeneca ($AZN) has won U.S. approval for a pen-injector version of once-weekly diabetes med Bydureon. News
> The FDA will increase access to morning-after pill generics. More
> The chronically ill are still facing high drug costs in the U.S. despite the ban on discriminatory health insurance practices against the sick. Story
@FierceMedDev: How to gain new stent sales in a sluggish market: bulk discount deals. Story | Follow @FierceMedDev
@MarkHFierce: For Covidien, a ventilation system wins a CE mark after other product setbacks in the space. More | Follow @MarkHFierce
@MichaelGFierce: New manufacturing technique offers tailored delivery nanoparticles made of iron, silver and silicon. Article from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: White noise sleep machines at full volume could cause hearing damage in infants, say researchers. News | Follow @EmilyWFierce
> Abbott and Medtronic are sharing a bulk discount deal to sell stents at 135 hospitals. More
> GE Ventures pours cash into RainDance's $16.5M Series E extension. Story
> BSD bets on new ablation device sales growth in its ongoing Terumo deal. More
Biotech News
@FierceBiotech: GlaxoSmithKline hits the brakes on an anti-inflammatory drug from Galapagos. News | Follow @FierceBiotech
@JohnCFierce: Remember that big Gilead bet on Pharmasset? It paid off and made John Martin a billionaire. Item | Follow @JohnCFierce
@DamianFierce: India's Lupin queues up for a share of the biosimilar boom. Story | Follow @DamianFierce
@EmilyMFierce: Experimental supplement extends lifespan, stops metabolic disease in mice. Article from FierceBiotechResearch | Follow @EmilyMFierce
> Roche racks up another PhIII setback as MetMab flops against lung cancer. News
> Scientific insights into brain chemistry trigger drug trials for Down syndrome. Story
> Investigators ID a rare antibody that may offer a key to elusive HIV vaccine. Research
CRO News
> InVentiv amps up its biosimilar efforts with latest deal. Story
> Report: VC giant Sequoia unloading $50M stake in India's GVK. News
> Quintiles touts its talent as cash rolls in. Article
> Cardialysis taps AG Mednet to handle an ocean of trial data. Story
> MPI's imaging team-up snags a cyclotron as it preps for opening day. Story
> Charles River looks to Exostar for cloud-based data platform. Brief
Biotech IT News
> Google joins genomics alliance as it prepares industry-focused cloud services. News
> Novartis' pitch to join trial data sharing bandwagon gets frosty reception. Story
> U.K. begins trying to rebuild trust in patient database after months of 'confusion, suspicion and anxiety.' Article
> FDA defends itself against accusations its email snooping broke whistleblower laws. Story
> George Washington University to trial 40-Gbps genomics data transfers with NIH. Article
> NIH adds genetic data from Kaiser, UCSF to online resource. Brief
And Finally... Public health officials are eyeing a debilitating mosquito-borne virus that could soon break out across large parts of the Americas. More (sub. req.)